Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan M Carnahan

Showing results (81-90 of 101) with videos related to

Pageof 11
Sort By:
Blood|October 8, 2015
Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancyEric M Ammann, Michael P Jones, Brian K Link, et al.
Journal of the American Heart Association|December 1, 2022
Cardiac Adverse Events Associated With Chemo-Radiation Versus Chemotherapy for Resectable Stage III Non-Small-Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare StudyEmma Herbach, Michael A O'Rorke, Ryan M Carnahan, et al.
Spine|February 17, 2023
Postoperative Use of the Muscle Relaxants Baclofen and/or Cyclobenzaprine Associated With an Increased Risk of Delirium Following Lumbar FusionEli A Perez, Emanuel Ray, Colin J Gold, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
The U.S. Food and Drug Administration's Mini-Sentinel program: status and directionRichard Platt, Ryan M Carnahan, Jeffrey S Brown, et al.
Medicine|February 22, 2018
Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed DatabaseEric M Ammann, Adam Cuker, Ryan M Carnahan, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
Impact of programs to reduce antipsychotic and anticholinergic use in nursing homesRyan M Carnahan, Grant D Brown, Elena M Letuchy, et al.
American Journal of Hematology|March 15, 2016
Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTsEric M Ammann, Cole B Haskins, Kelsey M Fillman, et al.
JCO Clinical Cancer Informatics|August 16, 2020
Exploration of PCORnet Data Resources for Assessing Use of Molecular-Guided Cancer TreatmentRyan M Carnahan, Lemuel R Waitman, Mary E Charlton, et al.
BMC Research Notes|July 14, 2019
Temporal trends and factors associated with increased mortality among atrial fibrillation weekend hospitalizations: an insight from National Inpatient Sample 2005-2014Dinesh C Voruganti, Ghanshyam Shantha, Sushma Dugyala, et al.
Pharmaceutical Medicine|January 15, 2020
Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin UsersRyan M Carnahan, Joshua J Gagne, Christian Hampp, et al.
Pageof 11

Showing results (81-90 of 101) with videos related to

Sort By:
Pageof 11
Blood|October 8, 2015
Intravenous immune globulin and thromboembolic adverse events in patients with hematologic malignancyEric M Ammann, Michael P Jones, Brian K Link, et al.
Journal of the American Heart Association|December 1, 2022
Cardiac Adverse Events Associated With Chemo-Radiation Versus Chemotherapy for Resectable Stage III Non-Small-Cell Lung Cancer: A Surveillance, Epidemiology and End Results-Medicare StudyEmma Herbach, Michael A O'Rorke, Ryan M Carnahan, et al.
Spine|February 17, 2023
Postoperative Use of the Muscle Relaxants Baclofen and/or Cyclobenzaprine Associated With an Increased Risk of Delirium Following Lumbar FusionEli A Perez, Emanuel Ray, Colin J Gold, et al.
Pharmacoepidemiology and Drug Safety|January 21, 2012
The U.S. Food and Drug Administration's Mini-Sentinel program: status and directionRichard Platt, Ryan M Carnahan, Jeffrey S Brown, et al.
Medicine|February 22, 2018
Chart validation of inpatient International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) administrative diagnosis codes for venous thromboembolism (VTE) among intravenous immune globulin (IGIV) users in the Sentinel Distributed DatabaseEric M Ammann, Adam Cuker, Ryan M Carnahan, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 11, 2017
Impact of programs to reduce antipsychotic and anticholinergic use in nursing homesRyan M Carnahan, Grant D Brown, Elena M Letuchy, et al.
American Journal of Hematology|March 15, 2016
Intravenous immune globulin and thromboembolic adverse events: A systematic review and meta-analysis of RCTsEric M Ammann, Cole B Haskins, Kelsey M Fillman, et al.
JCO Clinical Cancer Informatics|August 16, 2020
Exploration of PCORnet Data Resources for Assessing Use of Molecular-Guided Cancer TreatmentRyan M Carnahan, Lemuel R Waitman, Mary E Charlton, et al.
BMC Research Notes|July 14, 2019
Temporal trends and factors associated with increased mortality among atrial fibrillation weekend hospitalizations: an insight from National Inpatient Sample 2005-2014Dinesh C Voruganti, Ghanshyam Shantha, Sushma Dugyala, et al.
Pharmaceutical Medicine|January 15, 2020
Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin UsersRyan M Carnahan, Joshua J Gagne, Christian Hampp, et al.
Pageof 11